Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia

Lilliam Ambroggio, Jennifer A. Taylor, Loni Philip Tabb, Craig Newschaffer, Alison A. Evans, Samir S. Shah

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: To determine the comparative effectiveness of β-lactam monotherapy and β-lactam and macrolide combination therapy on clinical outcomes in the treatment of children hospitalized with community-acquired pneumonia (CAP). Study design: This multicenter retrospective cohort study included children aged 1-18 years who were hospitalized with CAP and received β-lactam antibiotic therapy either alone or in combination with a macrolide. Data were obtained from the Pediatric Health Information System. Associations between empiric antibiotic therapy and hospital readmission for the same episode of pneumonia were estimated using exact logistic regression. Associations between empiric antibiotic therapy and length of hospital stay were estimated using a generalized estimating equation with negative binomial distribution. Results: There were 20 743 patients hospitalized with CAP. Of these, 24% received β-lactam and macrolide combination therapy on admission. Compared with children who received β-lactam monotherapy, children who received β-lactam plus macrolide combination therapy were 20% less likely to stay in the hospital an additional day (adjusted relative risk 0.80; 95% CI, 0.75-0.86) but did not have a different readmission rate (relative risk 0.69; 95% CI, 0.41-1.12). An effect of combination treatment on reduced length of stay was not evident in children <6 years of age but increased with increasing age groups thereafter. Conclusion: School-aged patients hospitalized with CAP who received β-lactam plus macrolide combination therapy have a shorter length of stay and similar rates of readmission compared with school-aged patients who receive β-lactam monotherapy.

Original languageEnglish (US)
JournalJournal of Pediatrics
Volume161
Issue number6
DOIs
StatePublished - Jan 1 2012

Fingerprint

Lactams
Hospitalized Child
Macrolides
Pneumonia
Length of Stay
Therapeutics
Anti-Bacterial Agents
Binomial Distribution
Health Information Systems
Patient Readmission
Cohort Studies
Retrospective Studies
Age Groups
Logistic Models
Pediatrics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{6f91e8436d2e46a3a10f810bc2ff1ee1,
title = "Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia",
abstract = "Objective: To determine the comparative effectiveness of β-lactam monotherapy and β-lactam and macrolide combination therapy on clinical outcomes in the treatment of children hospitalized with community-acquired pneumonia (CAP). Study design: This multicenter retrospective cohort study included children aged 1-18 years who were hospitalized with CAP and received β-lactam antibiotic therapy either alone or in combination with a macrolide. Data were obtained from the Pediatric Health Information System. Associations between empiric antibiotic therapy and hospital readmission for the same episode of pneumonia were estimated using exact logistic regression. Associations between empiric antibiotic therapy and length of hospital stay were estimated using a generalized estimating equation with negative binomial distribution. Results: There were 20 743 patients hospitalized with CAP. Of these, 24{\%} received β-lactam and macrolide combination therapy on admission. Compared with children who received β-lactam monotherapy, children who received β-lactam plus macrolide combination therapy were 20{\%} less likely to stay in the hospital an additional day (adjusted relative risk 0.80; 95{\%} CI, 0.75-0.86) but did not have a different readmission rate (relative risk 0.69; 95{\%} CI, 0.41-1.12). An effect of combination treatment on reduced length of stay was not evident in children <6 years of age but increased with increasing age groups thereafter. Conclusion: School-aged patients hospitalized with CAP who received β-lactam plus macrolide combination therapy have a shorter length of stay and similar rates of readmission compared with school-aged patients who receive β-lactam monotherapy.",
author = "Lilliam Ambroggio and Taylor, {Jennifer A.} and Tabb, {Loni Philip} and Craig Newschaffer and Evans, {Alison A.} and Shah, {Samir S.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.jpeds.2012.06.067",
language = "English (US)",
volume = "161",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. / Ambroggio, Lilliam; Taylor, Jennifer A.; Tabb, Loni Philip; Newschaffer, Craig; Evans, Alison A.; Shah, Samir S.

In: Journal of Pediatrics, Vol. 161, No. 6, 01.01.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia

AU - Ambroggio, Lilliam

AU - Taylor, Jennifer A.

AU - Tabb, Loni Philip

AU - Newschaffer, Craig

AU - Evans, Alison A.

AU - Shah, Samir S.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective: To determine the comparative effectiveness of β-lactam monotherapy and β-lactam and macrolide combination therapy on clinical outcomes in the treatment of children hospitalized with community-acquired pneumonia (CAP). Study design: This multicenter retrospective cohort study included children aged 1-18 years who were hospitalized with CAP and received β-lactam antibiotic therapy either alone or in combination with a macrolide. Data were obtained from the Pediatric Health Information System. Associations between empiric antibiotic therapy and hospital readmission for the same episode of pneumonia were estimated using exact logistic regression. Associations between empiric antibiotic therapy and length of hospital stay were estimated using a generalized estimating equation with negative binomial distribution. Results: There were 20 743 patients hospitalized with CAP. Of these, 24% received β-lactam and macrolide combination therapy on admission. Compared with children who received β-lactam monotherapy, children who received β-lactam plus macrolide combination therapy were 20% less likely to stay in the hospital an additional day (adjusted relative risk 0.80; 95% CI, 0.75-0.86) but did not have a different readmission rate (relative risk 0.69; 95% CI, 0.41-1.12). An effect of combination treatment on reduced length of stay was not evident in children <6 years of age but increased with increasing age groups thereafter. Conclusion: School-aged patients hospitalized with CAP who received β-lactam plus macrolide combination therapy have a shorter length of stay and similar rates of readmission compared with school-aged patients who receive β-lactam monotherapy.

AB - Objective: To determine the comparative effectiveness of β-lactam monotherapy and β-lactam and macrolide combination therapy on clinical outcomes in the treatment of children hospitalized with community-acquired pneumonia (CAP). Study design: This multicenter retrospective cohort study included children aged 1-18 years who were hospitalized with CAP and received β-lactam antibiotic therapy either alone or in combination with a macrolide. Data were obtained from the Pediatric Health Information System. Associations between empiric antibiotic therapy and hospital readmission for the same episode of pneumonia were estimated using exact logistic regression. Associations between empiric antibiotic therapy and length of hospital stay were estimated using a generalized estimating equation with negative binomial distribution. Results: There were 20 743 patients hospitalized with CAP. Of these, 24% received β-lactam and macrolide combination therapy on admission. Compared with children who received β-lactam monotherapy, children who received β-lactam plus macrolide combination therapy were 20% less likely to stay in the hospital an additional day (adjusted relative risk 0.80; 95% CI, 0.75-0.86) but did not have a different readmission rate (relative risk 0.69; 95% CI, 0.41-1.12). An effect of combination treatment on reduced length of stay was not evident in children <6 years of age but increased with increasing age groups thereafter. Conclusion: School-aged patients hospitalized with CAP who received β-lactam plus macrolide combination therapy have a shorter length of stay and similar rates of readmission compared with school-aged patients who receive β-lactam monotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84869508253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869508253&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2012.06.067

DO - 10.1016/j.jpeds.2012.06.067

M3 - Article

C2 - 22901738

AN - SCOPUS:84869508253

VL - 161

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -